
Anthropic is set for a record-breaking $90bn (£68bn) share sale on Thursday, as the AI giant prepares to make its Nasdaq debut at a valuation of around $1.4 trillion despite weeks of turmoil across technology stocks.
The Claude developer is expected to price its shares on Wednesday evening, with bankers reportedly guiding investors towards the upper end of, or above, its proposed $70 to $78 range.
The offering has attracted orders for almost seven times the shares available, according to reports, including several bids worth $10bn or more.
At $78 per share, Anthropic would raise approximately $64.4bn through its public offering, with a further $26bn coming from a private placement involving technology giants including Nvidia and Google.
The combined $90.4bn raise would eclipse SpaceX’s $75bn offering earlier this year, making it the largest share sale on record.
Stay in the know
Three daily briefings with the key market moves and top business and political stories.
SUBSCRIBE HEREHowever, the listing comes after a sharp sell-off in AI stocks, with the Nasdaq 100 down around 13 per cent from its October peak as investors question the scale of spending on the technology.
Nvidia’s stronger-than-expected earnings on Tuesday offered some relief, with the chipmaker reporting quarterly revenue of $115.8bn, comfortably beating Wall Street forecasts.
David Morrison, senior market analyst at Trade Nation, said the results had a “calming effect on tech in general” following six weeks in which the AI trade appeared to be unravelling.
“Yet none of this looks likely to upend the Anthropic IPO,” he said, pointing to the offering’s heavy oversubscription. “Despite this, concerns over the overall AI trade haven’t gone away.”
Valuation divides analysts
Anthropic’s listing will give public market investors their first opportunity to buy shares in a leading frontier AI laboratory, ahead of rival OpenAI, which is not expected to float before 2027.
The company reported an annualised revenue run rate of $81bn at the end of October, up $10bn in a month, as demand for its Claude models and coding tools continued to grow.
But its spending commitments have also ballooned, with nearly $901bn pledged towards computing infrastructure and chips through 2045.
Around $71bn is due in the year to September 2027, while the company recorded a $567m operating loss in the third quarter.
Pitchbook has valued Anthropic at $1.42 trillion, equivalent to approximately $79 per share, slightly above the top of its proposed IPO range.
Anthropic’s dependence on major tech companies is also expected to attract scrutiny as it enters public markets.
Nvidia is investing approximately $10bn in the flotation while supplying a significant proportion of the chips used to run Anthropic’s models.
Google is also expected to invest $10bn, deepening the financial ties between the AI developer and the companies providing its computing infrastructure.
The listing comes as Anthropic faces questions over its safety commitments and the risks of deploying increasingly powerful AI systems.
The company operates as a public benefit corporation, with a governance structure designed to balance commercial interests against wider societal concerns.
Its prospectus warns that advanced AI could pose “catastrophic or existential risks to humanity” without adequate safeguards.
Andrew Strait, former head of societal resilience at the UK’s AI Security Institute, questioned whether public market pressures could undermine those commitments.
“An IPO only adds to the pressure to release products faster, despite fundamental security and safety problems in their products remaining unresolved,” he said.
He also warned that Anthropic’s growing dominance could deepen Britain’s dependence on American technology companies.
“Anthropic is seeking to become the intelligence layer that governments, businesses and universities depend on,” Strait said.
Despite the strong demand for shares, analysts have warned that Anthropic’s performance after listing could differ sharply from its heavily oversubscribed offering.
Anthropic is expected to become eligible for inclusion in the Russell 1000 on 11 December and the Nasdaq 100 on 21 December, potentially triggering additional demand from passive investment funds.